Q4 2024 Management View CEO Weibin Yan highlighted a 24.6% revenue growth to $16.2 million for fiscal year 2024, driven by higher corn seed sales and an improving market. He emphasized the receipt of ...

As a result, Healthpeak’s life science and medical office portfolios are now prominently featured in the company's portfolio as the proceeds from the senior housing sales were reinvested into these ...